Tamtam Try Tamtam free
Danone logo

Danone account plan

global food leader health

At a glance

Danone is a French food group in dairy, plant-based, specialized nutrition and waters, with €27,283m of 2025 sales and 88,670 employees.

Danone's mission is to bring health through food to as many people as possible, through three categories: Essential Dairy & Plant-Based, Specialized Nutrition (infant formula and medical nutrition) and Waters. Its brands include Activia, Actimel, Oikos, Alpro, Silk, Aptamil, Nutricia, evian and AQUA, sold through retail chains, traditional outlets, e-commerce, away-from-home and specialised channels such as hospitals and pharmacies. In 2025 sales were €27,283m (+4.5% like-for-like), recurring operating income €3,665m (13.4% margin) and net income group share €1,825m. It had 88,670 employees at December 31, 2025 and 151 production sites. Gilles Schnepp chairs the Board and Antoine de Saint-Affrique is CEO.

Business units

Strategic priorities

Renew Danone Chapter 2
Pivot categories (from yogurt to gut health and protein, from plant-based to plant-powered, from waters to healthy hydration), broaden business models such as homecare and away-from-home, and expand in the US, India and South-East Asia.
Mid-term financial model
For 2025-2028: 3-5% like-for-like sales growth, recurring operating income growing faster than sales, structurally double-digit ROIC and progress towards €3bn of sustainable free cash flow. 2026 guidance is in that range.
Fix North America
Add yogurt capacity line by line across 13 factories, relaunch Activia in H2 2026, enter kefir in the US and revive the Dannon brand with a new approach to Greek at the start of 2027, while moving Silk to the Alpro model.
Scale medical nutrition
Kate Farms with Nutricia forms a $500 million US medical nutrition platform; in China Danone targets deeper hospital penetration beyond tier 1.
Strategic channels and AI
Channels outside mass retail exceed 50% of sales and grow 2-3 times faster; AI is rolled out from Microsoft Copilot for everyone to supply chain, R&D and retailer engagement.

Latest results

In H1 2026 (six months ended June 30, 2026) sales were €13,936m, up 3.5% like-for-like and 1.4% reported, with Q2 like-for-like growth of 4.2%. Recurring operating income rose 2.3% to €1,854m and the margin to 13.3% (+12 bps), as overhead productivity offset the infant formula recall and the first inflation effects of the Middle East conflict. Net income group share rose 13.0% to €1,175m. Free cash flow fell to €852m from €1,172m as Danone built safety stocks, and net debt rose to €8,975m. 2026 guidance of 3% to 5% like-for-like growth with recurring operating income growing faster than sales was confirmed.

Investments and deals

Kate Farms
96% stake acquired July 1, 2025 for €839m ($983m), a US plant-based medical and everyday nutrition brand entering like-for-like from Q3 2026.
Huel
Definitive agreement on March 23, 2026 to acquire the complete-nutrition brand with strong direct-to-consumer sales in the UK, Europe and the US; closing expected in H2 2026.
MADE Group and the Australian dairy JV
Agreement on June 22, 2026 to buy Melbourne-based MADE Group (more than €300m of sales) and the remaining 49% of Danone Saputo Dairy Australia, which together would add more than EUR400 million of sales in APAC.
Argentina joint venture and disposals
A March 24, 2026 agreement with Arcor combines Danone Argentina with Mastellone Hermanos in a jointly governed venture; Proviva and Lunnarp in Sweden were sold on March 2, 2026.
Capacity capex
Capex was €1,055m in 2025 and €414m in H1 2026, for high protein and medical nutrition capacity, and may rise to 4.5% of sales.

Challenges and risks

Infant formula recall
The January 2026 recall in Europe and the Middle East cost €42m of non-recurring costs in H1 2026 and has led to claims in several jurisdictions; Europe remains a mixed bag.
Middle East conflict and cost inflation
The conflict disrupts logistics in the region and raises energy, transport, packaging and some raw material costs; the EDP margin fell 68 bps in H1 2026 before price increases.
US EDP competitiveness
The CEO has stated dissatisfaction with parts of the North American EDP portfolio: coffee creamers, plant-based (Silk) and non-protein yogurt starved of capacity.
China dependence
China is about 12% of sales and the largest profit contributor, and infant formula sold there is mostly made abroad; Mizone was a drag in Q2 2026.

What leadership says

“the food industry is at a tipping point and health through food has never been more relevant”

Antoine de Saint-Affrique, Chief Executive Officer · H1 2026 results conference call, July 29, 2026

“It is clear that in the US, our performance in 2025 didn't meet our expectations. We are not where we should be, and we know we need to step up our game.”

Antoine de Saint-Affrique, Chief Executive Officer · FY 2025 results conference call, February 20, 2026

“Protein is here to stay. Penetration of GLP-1 is still nowhere”

Antoine de Saint-Affrique, Chief Executive Officer · Fireside chat at an investor conference in Boston, September 8, 2026

“volume, volume, volume and mix will remain our priority number one”

Juergen Esser, Deputy CEO and Chief Financial Officer · Fireside chat at an investor conference in Boston, September 8, 2026

Where a supplier can help

Supply chain resilience
Safety stocks built against Middle East disruption and higher packaging and energy costs make supply planning, sourcing and logistics optimisation suppliers relevant to that challenge.
US capacity ramp-up
The North America fix depends on adding yogurt capacity line by line across 13 factories: equipment, automation and manufacturing-execution vendors fit this priority.
Direct-to-consumer and community marketing
Huel brings direct-to-consumer and community capabilities Danone says it lacks; e-commerce, content and community-management tools can support the integration and the push into strategic channels.
Healthcare channel reach
Scaling medical nutrition through hospitals, pharmacies and healthcare professionals in the US and China calls for medical sales enablement, health economics and HCP engagement partners.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Danone?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Danone

What does Danone do?

Danone makes dairy and plant-based products, infant and medical nutrition, and bottled waters, with brands such as Activia, Oikos, Alpro, Aptamil, Nutricia and evian.

What is Danone's revenue?

Sales were €27,283m in 2025 and €13,936m in H1 2026, up 3.5% like-for-like.

How many employees does Danone have?

Danone had 88,670 employees at December 31, 2025.

Who leads Danone?

Antoine de Saint-Affrique is CEO, Juergen Esser is Deputy CEO and CFO, and Gilles Schnepp chairs the Board.

What is Danone's strategy?

Renew Danone Chapter 2 pivots the portfolio to health categories such as protein, gut health and medical nutrition, broadens channels and expands in the US and emerging markets, targeting 3-5% like-for-like growth.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)